Tyra Biosciences, Inc.TYRANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+33.8%
5Y CAGR+70.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+33.8%/yr
Annual compound
5Y CAGR
+70.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
14.3x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $102.93M | +28.5% |
| 2024 | $80.08M | +28.1% |
| 2023 | $62.52M | +45.4% |
| 2022 | $43.01M | +108.4% |
| 2021 | $20.64M | +186.5% |
| 2020 | $7.20M | +302.4% |
| 2019 | $1.79M | - |